Crane NXT, Co. — Director's Dealing 2018

Feb 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRANE CO /DE/ (CR)
CIK: 0000025445
Period of Report: 2018-02-22

Reporting Person: Lavish James A. (VP, CBS, People & Performance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	M	2089	$64.78	Acquired	16997	Direct
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	S	2089	$94.895	Disposed	14908	Direct
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	M	2662	$58.47	Acquired	17570	Direct
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	S	2662	$94.895	Disposed	14908	Direct
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	M	5368	$43.57	Acquired	20276	Direct
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	S	5368	$94.895	Disposed	14908	Direct
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	M	2865	$73.90	Acquired	17773	Direct
2018-02-22	CRANE CO. COMMON, PAR VALUE $1.00	S	2865	$94.895	Disposed	14908	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-22	Employee Stock Option (Right to Buy)	$64.78	M	2089	Disposed	2024-01-27	CRANE CO. COMMON, PAR VALUE $1.00 (2089.0)	Direct
2018-02-22	Employee Stock Option (Right to Buy)	$58.47	M	2662	Disposed	2025-01-26	CRANE CO. COMMON, PAR VALUE $1.00 (2662.0)	Direct
2018-02-22	Employee Stock Option (Right to Buy)	$43.57	M	5368	Disposed	2026-01-25	CRANE CO. COMMON, PAR VALUE $1.00 (5368.0)	Direct
2018-02-22	Employee Stock Option (Right to Buy)	$73.9	M	2865	Disposed	2027-01-30	CRANE CO. COMMON, PAR VALUE $1.00 (2865.0)	Direct

Footnotes

F1: Concurrent sale of shares resulting from an exercise of options granted on 1/27/2014 and expiring on 1/27/2024.

F2: Weighted average price at which shares were sold in multiple same-day transactions at prices ranging from $94.23 to $95.39. The reporting person undertakes to provide, upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Concurrent sale of shares resulting from an exercise of options granted on 1/26/2015 and expiring on 1/26/2025.

F4: Concurrent sale of shares resulting from an exercise of options granted on 1/25/2016 and expiring on 1/25/2026.

F5: Concurrent sale of shares resulting from an exercise of options granted on 1/30/2017 and expiring on 1/30/2027.

F6: This option vested 25% on the first and 50% on the second, 75% on the third and 100% on the fourth anniversary of the date of grant (1/27/2014).

F7: The remaining 25% will vest on the fourth anniversary of the grant date (01/26/2015).

F8: This option vested 25% on the first and 50% on the second anniversary of the grant date (01/25/2016). The remaining 50% will vest on the third and fourth anniversary of the grant date.

F9: This option vested 25% on the first anniversary of the grant date (01/30/2017). The remaining 75% will vest on the second, third and fourth anniversary of the grant date.